Dr. Bernard Le Foll is a Clinician Scientist specializing in addiction. He is Head of the Translational Addiction Research Laboratory in the Campbell Family Mental Health Research Institute. He is also the Medical Head of the Concurrent Outpatient Medical and Psychosocial Addiction Support Service (COMPASS) in the Acute Care Program, delivering outpatient addiction services to several thousand patients per year at CAMH, and Head of the Alcohol Research and Treatment Clinic at CAMH. He is Professor at University of Toronto in the departments of Family and Community Medicine, Pharmacology, Psychiatry and Institute of Medical Sciences.
Areas of Research
Dr. Le Foll's clinical activity is centred on drug addiction. He received specialized training in drug addiction and behavioral and cognitive therapy at Paris University in France. He has written treatment guidelines and has been coordinator of clinical trials. He obtained a PhD in pharmacology at INSERM and completed a Fogarty Visiting Fellowship at the National Institutes of Health.
The goal of his research is to improve treatment of drug addiction. For this purpose, various approaches are used such as clinical trials, laboratory experiments and multi-disciplinary basic research approaches. The goal is to develop novel therapeutic strategies in clinical populations.
He has received scientific prizes and awards from the Canadian Institutes for Health Research, the National Institutes of Health, the French Academy of Medicine, the American College for Neuropsychopharmacology, the College on Problems on Drug Dependence, the Society for Research on Nicotine and Tobacco, the Brain and Behavior Foundation, Pfizer, OPGRC, the Ontario Lung Association and the Heart and Stroke Foundation.
View Dr. Le Foll's publications on PubMed.